Canadian International Pharma Corp. announces that at its annual general and special meeting held on December 7, 2020, the shareholders appointed Drew Bonnell as a director of the Company. Douglas Mason and Ron Schmitz were also nominated to continue as directors and Andrzej Kowalski did not stand for re-election as a director but remains as the Company’s chief financial officer.